Life-extension therapy: Anthelmintic drug Ivermectin inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 2/August/2017, 11.18 pm

Natural product-derived therapy for therapy-resistant cancers: Geranylgeranoic acid (GGA), isolated from schisandra chinensis berry, inhibits the expression of phospholipid glutathione peroxidase (GPX4), inhibits GPX4 signaling network and lipid peroxidase pathway, suppresses EMT protein ZEB1, increases sensitivity to anticancer therapy and prolongs survival via up regulation of its target gene, 2/August/2017, 10.10 pm
August 2, 2017
Regenerative therapy for improving memory in aged individuals: Baraprost sodium, a prostacyclin analogue, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning via down regulation of its target genes, 3/July/2017, 10.18 pm
August 3, 2017
Show all

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports, for the first time, that:  Life-extension therapy: Anthelmintic drug Ivermectin inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span 

 

 

 

 

 

 


Research findings to Therapeutic opportunity: 

 Ivermectin, by  increasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).   

Figure 1. Mechanistic insight into how Ivermectin may extend lifespan. Ivermectin may promote longevity by suppressing the expression of p70 S6 kInase

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing Ivermectin or its analogs, either alone or in combination with any of the known longevity-promoting compound(s)” may be used to extend the lifespan of an individual (fig. 1).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How  Ivermectin decreases the expression of p70 S6 Kinase and promotes mammalian life span

# Research cooperation

Amount: $100#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L.,  Life-extension therapy: Anthelmintic drug Ivermectin inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 2/August/2017, 11.18 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.